Geron Corporation (GERN)
NASDAQ: GERN · IEX Real-Time Price · USD
3.790
+0.230 (6.46%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Geron Employees
Geron had 141 employees on December 31, 2023. The number of employees increased by 34 or 31.78% compared to the previous year.
Employees
141
Change (1Y)
34
Growth (1Y)
31.78%
Revenue / Employee
$1,681
Profits / Employee
-$1,305,865
Market Cap
2.23B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 141 | 34 | 31.78% |
Dec 31, 2022 | 107 | 35 | 48.61% |
Dec 31, 2021 | 72 | 17 | 30.91% |
Dec 31, 2020 | 55 | 9 | 19.57% |
Dec 31, 2019 | 46 | 28 | 155.56% |
Dec 31, 2018 | 18 | 0 | - |
Dec 31, 2017 | 18 | 0 | - |
Dec 31, 2016 | 18 | -2 | -10.00% |
Dec 31, 2015 | 20 | -22 | -52.38% |
Dec 31, 2014 | 42 | -4 | -8.70% |
Dec 31, 2013 | 46 | -59 | -56.19% |
Dec 31, 2012 | 105 | -73 | -41.01% |
Dec 31, 2011 | 178 | 3 | 1.71% |
Dec 31, 2010 | 175 | 3 | 1.74% |
Dec 31, 2009 | 172 | 13 | 8.18% |
Dec 31, 2008 | 159 | 19 | 13.57% |
Dec 31, 2007 | 140 | 37 | 35.92% |
Dec 31, 2006 | 103 | 13 | 14.44% |
Dec 31, 2005 | 90 | 24 | 36.36% |
Dec 31, 2004 | 66 | 13 | 24.53% |
Dec 31, 2003 | 53 | -39 | -42.39% |
Dec 31, 2002 | 92 | -50 | -35.21% |
Dec 31, 2001 | 142 | 30 | 26.79% |
Dec 31, 2000 | 112 | 9 | 8.74% |
Dec 31, 1999 | 103 | 6 | 6.19% |
Dec 31, 1998 | 97 | 8 | 8.99% |
Dec 31, 1997 | 89 | 0 | - |
Dec 31, 1996 | 89 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
ICU Medical | 14,000 |
Patterson Companies | 7,600 |
Teladoc Health | 5,600 |
Integra LifeSciences Holdings | 3,946 |
Tandem Diabetes Care | 2,400 |
Inari Medical | 1,300 |
STAAR Surgical Company | 1,115 |
Arvinas | 445 |
GERN News
- 2 days ago - Geron to Announce First Quarter 2024 Financial Results on May 2, 2024 - Business Wire
- 9 days ago - Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 24 days ago - Geron to Participate at Upcoming Investor Conferences in April - Business Wire
- 5 weeks ago - Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants - Business Wire
- 5 weeks ago - Can Geron Corporation maintain momentum following FDA's backing? - Invezz
- 6 weeks ago - Geron's stock soars 95% after FDA advisory panel votes in favor of blood-disorder drug - Market Watch
- 6 weeks ago - Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS - Business Wire
- 6 weeks ago - Geron's blood disorder drug gets FDA advisers' backing - Reuters